Health Care·Managed Health Care·$25.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $12.56 | N/A | +21.46% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $12.56 | N/A | +21.46% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism regarding future growth. They emphasized their commitment to navigating current challenges effectively.
Management highlighted strong performance in the Medicare Advantage segment.
They noted ongoing challenges but expressed confidence in their long-term strategy.
Humana's strong EPS performance, exceeding expectations by over 21%, contributed to a positive stock reaction, with shares rising 3.25%. The company continues to perform well in its Medicare Advantage segment, which may support future growth. However, the lack of revenue data and guidance leaves some uncertainty for investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MARATHON PETE CORP
Aug 3, 2020